Terms: = Lung cancer AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3 AND Treatment
11 results:
1. Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors.
Swart EM; Noordhof AL; Damhuis RAM; Kunst PWA; De Ruysscher DKM; Hendriks LEL; van Geffen WH; Aarts MJ
Lung Cancer; 2023 Aug; 182():107290. PubMed ID: 37419045
[TBL] [Abstract] [Full Text] [Related]
2. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
[TBL] [Abstract] [Full Text] [Related]
3. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
[TBL] [Abstract] [Full Text] [Related]
4. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Saussele S; Richter J; Guilhot J; Gruber FX; Hjorth-Hansen H; Almeida A; Janssen JJWM; Mayer J; Koskenvesa P; Panayiotidis P; Olsson-Strömberg U; Martinez-Lopez J; Rousselot P; Vestergaard H; Ehrencrona H; Kairisto V; Machová Poláková K; Müller MC; Mustjoki S; Berger MG; Fabarius A; Hofmann WK; Hochhaus A; Pfirrmann M; Mahon FX;
Lancet Oncol; 2018 Jun; 19(6):747-757. PubMed ID: 29735299
[TBL] [Abstract] [Full Text] [Related]
5. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract] [Full Text] [Related]
6. Infant pleuropulmonary blastoma: report of a rare case and review of literature.
Zhang H; Xu CW; Wei JG; Zhu GJ; Xu S; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13571-7. PubMed ID: 26722577
[TBL] [Abstract] [Full Text] [Related]
7. Clinical interrogation and application of super-selective intracranial artery infusion chemotherapy for lung cancer patients with brain metastases.
Rong J; Chunhua M; Yuan L; Ning M; Jinduo L; Bin W; Liwei S
Indian J Cancer; 2015 Nov; 52 Suppl 1():e22-5. PubMed ID: 26548934
[TBL] [Abstract] [Full Text] [Related]
8. Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and myod1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy.
Jiang H; Wang H; Wang S; Pei Z; Fu Z; Fang C; Wang J; Lu Q; Wang E; Li J
Mol Med Rep; 2015 May; 11(5):3523-32. PubMed ID: 25573098
[TBL] [Abstract] [Full Text] [Related]
9. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
[TBL] [Abstract] [Full Text] [Related]
10. Hemihypertrophy and a poorly differentiated embryonal rhabdomyosarcoma of the pelvis.
Samuel DP; Tsokos M; DeBaun MR
Med Pediatr Oncol; 1999 Jan; 32(1):38-43. PubMed ID: 9917751
[TBL] [Abstract] [Full Text] [Related]
11. Malignant rhabdoid tumor. A study with two established cell lines.
Ota S; Crabbe DC; Tran TN; Triche TJ; Shimada H
Cancer; 1993 May; 71(9):2862-72. PubMed ID: 8385567
[TBL] [Abstract] [Full Text] [Related]
